New Information

General director delivered a lecture in America

This November, General Director Kamakura was invited to lecture at the University of California, San Diego, (UCSD) in the United States. In addition, he exchanged information on medical technology with Steven R. Cohen, MD, an authority on plastic surgery in America. He then visited the US head office of Cytori Therapeutics, Inc., a developer of the Celution System, to inspect the manufacturing process and to have a meeting for improvement of quality and technology.

Lecture by General Director Kamakura

General Director Kamakura was invited to lecture at the University of California, San Diego, (UCSD) in the United States that the invitation was extended because Steven R. Cohen, MD, an authority on plastic surgery in America, observed the transplantation of adipose-derived stem cells performed by General Director Kamakura when Dr. Cohen came to Japan.

Date: Feb. 11, 2009
Location: University of California, San Diego
Title of lecutre: Transplantation adipose-derived stem cells with the Celution System
(Clinical Trial for Adipose Derived Stem and Regenerative Cells Assisted Breast Augmentation with the Celution System)

Note1: Steven R. Cohen, MD

A clinical professor at UCSD who is an authority on plastic surgery and who was named one of the top 10 physicians in the United States. In addition, he provides aesthetic surgery in general as the director of the Faces Plus Aesthetic Facility in San Diego.

Note 2: University of California, San Diego (UCSD)

UCSD is a public, coeducational university located in La Jolla, San Diego, California, USA, and is one of ten University of California campuses. Teaching staff at the university includes eight Novel Prize winners. Dr. Susumu Tonegawa, who won the Nobel Prize in Physiology or Medicine, is also a graduate of USCD.

Exchanging information with Steven R. Cohen, MD

Information on medical technology was exchanged with Steven R. Cohen, MD, an authority on plastic surgery in America.

Date: Feb. 11 and 12, 2009
Location: [1] Faces Plus Clinic (8899 University Center Lane, Suite 350, San Diego, California)
[2] Sharp Memorial Hospital (7901 Frost St. San Diego, California)

Meeting at the US head office of Cytori Therapeutics, Inc.

With the tremendous efforts of Cytori Therapeutics, Inc., (San Diego, USA) in November 2007, the Cosmetic Surgery Seishin Regenerative Medicine introduced technology for the transplantation of adipose stem cells using the Celution System for aesthetic purposes for the first time in the world. Currently, we have experience in more than 130 breast augmentation cases using transplantation of adipose stem cells with the Celution System in three clinics: Tokyo, Osaka, and Fukuoka. We visited Cytori to inspect the manufacturing process for the Celution System and to have a meeting to discuss improvements in quality and technology.

Click here to see Celution breast augmentation (transplantation of adipose-derived stem cells)

Click here to go to the webpage of Cosmetic Surgery Seishin

Celution System

●High-performance System for Extraction of Adipose Tissue-derived Stem Cells

This high-performance system for extraction of adipose tissue-derived stem cells developed by Cytori Therapeutics, Inc., has the following advantages over conventional manual extraction of stem cells:

(1) More consistent volume of stem cells extracted
(2) Shorter time needed for extraction
(3) Better conditions of stem cells
(4) Minimal risk of exposure to exogenous infectious agents
(5) Reduction in labor costs
(6) Easier procedures for extraction


The system has been proven safe as evidenced by ISO 10993 certification, CE mark, and FDA approval. (In Japan, the Ministry of Health, Labour and Welfare accepted notification of the system as a medical device for analysis and testing of stem cells in October 2007.) Clinical application of the Celution System has started in many countries around the world, and the system is now used clinically in about 22 medical institutions in Germany, Spain, and other countries.

◇Cytori Therapeutics, Inc., in the United States

Cytori Therapeutics is a global leader in the development of devices for regenerative medicine and has developed the Celution System. Projects for practical application of the Celution System in breast reconstruction and treatment of cardiovascular disease and other disorders are now ongoing primarily in Europe and the United States.

page top